Credit Suisse Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
Similar funds
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.